POTENTIATION OF CHLOROFORM-INDUCED HEPATOTOXICITY BY METHYL ISOBUTYL KETONE AND 2 METABOLITES

被引:13
|
作者
VEZINA, M [1 ]
KOBUSCH, AB [1 ]
DUSOUICH, P [1 ]
GRESELIN, E [1 ]
PLAA, GL [1 ]
机构
[1] UNIV MONTREAL,FAC MED,DEPT PHARMACOL,CP 6128,SUCCURSALE A,MONTREAL H3C 3J7,QUEBEC,CANADA
关键词
CHCl[!sub]3[!/sub] hepatotoxicity; enzyme induction; methyl isobutyl ketone; methyl isobutyl ketone metabolites; potentiation;
D O I
10.1139/y90-159
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The hepatonecrogenic properties of chloroform (CHCl3) can be modified by the administration of various chemicals. The ability of methyl isobutyl ketone (MIBK) and its two major metabolites, 4-methyl-2-pentanol (4MPOL) and 4-hydroxymethyl isobutyl ketone (4-OHMIBK) to potentiate the liver injury induced by CHCl3 was assessed in rats. The parent compound and both metabolites significantly increased the liver damage induced by CHCl3, as demonstrated by the elevation of the plasma activity of two transferases alanine aminotransferase and ornithine carbamoyl transferase and by the severity of the morphological changes. Moreover, the minimally effective dosage needed to potentiate CHCl3-induced hepatotoxicity was approximately 5 mmol/kg for the three compounds. We also studied the inducing properties of MIBK (cytochrome P-450 liver content and the activity of aniline hydroxylase, 7-ethoxycoumarin O-deethylase, and aminopyrine N-demethylase). Cytochrome P-450 content and the oxidation of aniline and 7-ethoxycoumarin were significantly increased with either a single (7.5 mmol/kg or greater) or a multiple (5.0 and 7.5 mmol · kg-1 · day-1 for 5 days) administration of MIBK. An increase in the activity of the aminopyrine demethylase was also elicited by the repetitive administration of MIBK. With gel electrophoresis, we found that MIBK significantly increased the 52.1- and 54.1-kDa proteins, corresponding most probably to P-450 isozymes.
引用
收藏
页码:1055 / 1061
页数:7
相关论文
共 50 条
  • [1] INVESTIGATION OF THE MECHANISM OF THE POTENTIATION OF CHLOROFORM-INDUCED HEPATOTOXICITY AND NEPHROTOXICITY BY METHYL NORMAL-BUTYL KETONE
    BRANCHFLOWER, RV
    POHL, LR
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1981, 61 (03) : 407 - 413
  • [2] EVIDENCE FOR THE INVOLVEMENT OF ORGANELLES IN THE MECHANISM OF KETONE-POTENTIATED CHLOROFORM-INDUCED HEPATOTOXICITY
    HEWITT, LA
    PALMASON, C
    MASSON, S
    PLAA, GL
    LIVER, 1990, 10 (01): : 35 - 48
  • [3] TEMPORAL RELATIONSHIPS BETWEEN BIOTRANSFORMATION, DETOXICATION, AND CHLORDECONE POTENTIATION OF CHLOROFORM-INDUCED HEPATOTOXICITY
    HEWITT, LA
    CAILLE, G
    PLAA, GL
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1986, 64 (04) : 477 - 482
  • [4] ROLE OF GLUTATHIONE IN CHLOROFORM-INDUCED HEPATOTOXICITY
    DOCKS, EL
    KRISHNA, G
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1976, 24 (01) : 13 - 22
  • [5] TEMPORAL VARIATIONS IN CHLOROFORM-INDUCED HEPATOTOXICITY IN RATS
    LAVIGNE, JG
    BELANGER, PM
    DORE, F
    LABRECQUE, G
    TOXICOLOGY, 1983, 26 (3-4) : 267 - 273
  • [6] ACUTE ALTERATION OF CHLOROFORM-INDUCED HEPATOTOXICITY AND NEPHROTOXICITY BY NORMAL-HEXANE, METHYL NORMAL-BUTYL KETONE, AND 2,5-HEXANEDIONE
    HEWITT, WR
    MIYAJIMA, H
    COTE, MG
    PLAA, GL
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1980, 53 (02) : 230 - 248
  • [7] RELATIONSHIP BETWEEN THE CARBON SKELETON LENGTH OF KETONIC SOLVENTS AND POTENTIATION OF CHLOROFORM-INDUCED HEPATOTOXICITY IN RATS
    HEWITT, WR
    BROWN, EM
    PLAA, GL
    TOXICOLOGY LETTERS, 1983, 16 (3-4) : 297 - 304
  • [8] POTENTIATION OF LITHOCHOLIC-ACID-INDUCED CHOLESTASIS BY METHYL ISOBUTYL KETONE
    JOSEPH, LD
    YOUSEF, IM
    PLAA, GL
    SHARKAWI, M
    TOXICOLOGY LETTERS, 1992, 61 (01) : 39 - 47
  • [9] ACUTE ALTERATION OF CHLOROFORM-INDUCED HEPATOTOXICITY BY MIREX AND KEPONE
    CIANFLONE, DJ
    HEWITT, WR
    PLAA, GL
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1979, 48 (01) : A156 - A156
  • [10] METHYL ISOBUTYL KETONE METABOLITES AND POTENTIATION OF THE CHOLESTASIS INDUCED IN RATS BY A MANGANESE-BILIRUBIN COMBINATION OR MANGANESE ALONE
    VEZINA, M
    PLAA, GL
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1988, 92 (03) : 419 - 427